Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Declèves

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 14, 2023
The Use of Levothyroxine Absorption Tests in Clinical PracticePhilippe Caron, Xavier Declèves
Antimicrobial Agents and Chemotherapy|October 18, 2012
Reduced pupil diameter in volunteers on stable buprenorphine maintenance therapy with telaprevir: a drug-drug interaction involving p-glycoprotein at the blood-brain barrier?Bruno Mégarbane, Hisham Alhaddad, Xavier Declèves
Pharmaceutics|April 3, 2021
Transient Receptor Potential Vanilloid in the Brain Gliovascular Unit: Prospective Targets in TherapyHuilong Luo, Xavier Declèves, Salvatore Cisternino
Anaesthesia, Critical Care & Pain Medicine|February 9, 2016
Is extracorporeal treatment useful for managing severe baclofen poisoning? - The debate is still openBruno Mégarbane, Laurence Labat, Xavier Declèves
Medecine Sciences : M/S|January 7, 2020
[New formats for improving brain drug delivery of antibodies: the blood-brain barrier case]Pierre Lafaye, Dominique Lesuisse, Xavier Declèves
Biologie Aujourd'Hui|November 23, 2012
[Recent advances in quantitative proteomics as a sensitive tool to quantify drug transporters and drug metabolizing enzymes at the human blood-brain barrier]Aude Jacob, Xavier Declèves, Jean-Michel Scherrmann
Clinical Toxicology (Philadelphia, Pa.)|October 26, 2021
Gliclazide disposition in overdose - a case report with pharmacokinetic modelingBruno Mégarbane, Lucie Chevillard, Nihel Khoudour, et al.
Pharmacological Research|October 4, 2016
The effect of morbid obesity on morphine glucuronidationCelia Lloret-Linares, Jean-Michel Scherrmann, Xavier Declèves
Pharmaceutical Research|March 7, 2018
Double or Simple Emulsion Process to Encapsulate Hydrophilic Oxytocin Peptide in PLA-PEG NanoparticlesBetty Gourdon, Xavier Declèves, Jean-Manuel Péan, et al.
Toxicology and Applied Pharmacology|September 19, 2006
Is P-glycoprotein (ABCB1) a phase 0 or a phase 3 colchicine transporter depending on colchicine exposure conditions?Xavier Declèves, Elisabeth Niel, Marcel Debray, et al.
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Endocrinology and Metabolism|March 14, 2023
The Use of Levothyroxine Absorption Tests in Clinical PracticePhilippe Caron, Xavier Declèves
Antimicrobial Agents and Chemotherapy|October 18, 2012
Reduced pupil diameter in volunteers on stable buprenorphine maintenance therapy with telaprevir: a drug-drug interaction involving p-glycoprotein at the blood-brain barrier?Bruno Mégarbane, Hisham Alhaddad, Xavier Declèves
Pharmaceutics|April 3, 2021
Transient Receptor Potential Vanilloid in the Brain Gliovascular Unit: Prospective Targets in TherapyHuilong Luo, Xavier Declèves, Salvatore Cisternino
Anaesthesia, Critical Care & Pain Medicine|February 9, 2016
Is extracorporeal treatment useful for managing severe baclofen poisoning? - The debate is still openBruno Mégarbane, Laurence Labat, Xavier Declèves
Medecine Sciences : M/S|January 7, 2020
[New formats for improving brain drug delivery of antibodies: the blood-brain barrier case]Pierre Lafaye, Dominique Lesuisse, Xavier Declèves
Biologie Aujourd'Hui|November 23, 2012
[Recent advances in quantitative proteomics as a sensitive tool to quantify drug transporters and drug metabolizing enzymes at the human blood-brain barrier]Aude Jacob, Xavier Declèves, Jean-Michel Scherrmann
Clinical Toxicology (Philadelphia, Pa.)|October 26, 2021
Gliclazide disposition in overdose - a case report with pharmacokinetic modelingBruno Mégarbane, Lucie Chevillard, Nihel Khoudour, et al.
Pharmacological Research|October 4, 2016
The effect of morbid obesity on morphine glucuronidationCelia Lloret-Linares, Jean-Michel Scherrmann, Xavier Declèves
Pharmaceutical Research|March 7, 2018
Double or Simple Emulsion Process to Encapsulate Hydrophilic Oxytocin Peptide in PLA-PEG NanoparticlesBetty Gourdon, Xavier Declèves, Jean-Manuel Péan, et al.
Toxicology and Applied Pharmacology|September 19, 2006
Is P-glycoprotein (ABCB1) a phase 0 or a phase 3 colchicine transporter depending on colchicine exposure conditions?Xavier Declèves, Elisabeth Niel, Marcel Debray, et al.
Pageof 13